Cure My Disease

Don't miss your cure!

 Log in / Sign up

Training the Brain's CEO: a new program aims to help kids with autism plan, organize, and stay in control

NCT ID NCT07801833

Symptom relief Sponsor: Seoul National University Bundang Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 03, 2026 · Last updated Sep 04, 2026 · Updated 1 time

Summary

This trial tests a structured, group-based training program designed to improve executive function skills in elementary school children aged 9 to 12 with autism spectrum disorder. Over 12 weeks, children attend weekly sessions that teach planning, organization, time management, emotional control, and flexible thinking, while parents join separate sessions to support these skills at home. Researchers compare the training group to a waitlist control group to see if the program improves daily executive function, adaptive behavior, and self-regulation. The goal is to determine whether this non-drug approach can help children apply these skills in real-life settings.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A structured, group-based executive function training program for children and their parents
What this could lead to
If effective, this program could offer a practical, non-drug way to help children with autism manage daily tasks and emotions, improving their independence and quality of life.
What could go wrong
The trial is small (40 participants) and early, so results may not apply broadly. The program requires weekly attendance and home practice, and benefits may vary among children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Mar 2026

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

9 to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children aged 9 to 12 years who are attending elementary school * Diagnosis of autism spectrum disorder (ASD) based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) * Full-scale intelligence quotient (IQ) of 70 or higher * Ability to understand the study procedures and participate in the intervention program * Availability of a parent or legal guardian who is able to participate in the parent sessions and study assessments Exclusion Criteria: * Presence of a severe neurological or medical condition that may interfere with participation in the study * Presence of a severe psychiatric or behavioral condition that may interfere with participation in the group-based intervention * Significant sensory or physical impairment that would prevent participation in the intervention or assessments * Concurrent participation in another structured intervention program targeting executive function during the study period

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Autism spectrum disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autism spectrum disorder Self-Control

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Autism spectrum disorder

Contacts and locations

Locations

  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do, 13620, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.